News Conference News CRT 2023 Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months Yael L. Maxwell February 28, 2023
News Conference News TCT 2022 RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP Todd Neale September 18, 2022
News Conference News EuroPCR 2022 Registry Data Hint at MACE Benefit With Renal Denervation Michael O'Riordan May 17, 2022
News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
News Conference News TCT 2018 Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO Todd Neale September 21, 2018
News Conference News EuroPCR 2018 Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension Michael O'Riordan May 23, 2018
News Conference News EuroPCR 2014 Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients Yael L. Maxwell May 22, 2014
News Conference News EuroPCR 2014 SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings Yael L. Maxwell May 22, 2014
News Conference News ACC 2014 ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation Yael L. Maxwell April 03, 2014
News Conference News ACC 2014 Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation Yael L. Maxwell March 30, 2014
News Conference News ACC 2014 Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure Yael L. Maxwell March 29, 2014
News Conference News ESC 2013 Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation Caitlin E. Cox September 04, 2013